| Allomicrovac |
A combined microbicidal-immunizing strategy against SIV and HIV infection |
| CILMALVAC |
The Tetrahymena system as an innovative approach to malaria antigene expression |
| DETECTHIV |
Sensitive Nanoparticle Assay For the Detection of HIV |
| EPIVAC |
Development of a multi-step Improved Epidermis Specific Vaccine Candidate against HIV/AIDS |
| EUROPRISE |
European Vaccines and Microbicides Enterprise |
| GISHEAL |
Genetic and Immunological Studies of European and African HIV-1+ Long Term Non-Progressors |
| HIV PI resistance |
HIV protease inhibitor resistance by enzyme- substrate coevolution |
| HIVResInh |
Preparation and Identification of New HIV Reverse Transcriptase
Inhibitors Targeted Against HIV Strains Resistant to anti-HIV/AIDS
drugs |
| HUMALMAB |
Human monoclonal antibodies as tools for malaria research and therapy |
| Immuno VacTB |
A new approach for developing a less Immunosuppressive Vaccine for Tuberculosis |
| INNOVAC |
Highly Innovative Strategies for Vaccination to Poverty Related Diseases |
| MUNANO VAC |
Mucosal Nano Vaccine Candidate for HIV |
| MVACTOR |
Host Immune Activation Optimised Vaccinia Virus Vectors for Vaccine Development |
| NEAT |
The European AIDS Treatment Network |
| Plasmodium dUTPase |
Deoxyuridine Triphosphate Nucleotidohydrolase as a Drug Target against Malaria |
| TBIRIS |
Pathogenesis and identification of predictive factors of TB-IRIS in HIV patients under HAART |